Nektar Therapeutics

BRINGING THERAPY TO LIFE

Pharmaceutical preparations having enhanced drug performance and/or drug delivery performance for the treatment and/or prophylaxis of diseases or medical conditions such as diabetes, infections, cancers, inflammations, respiratory and pulmonary conditions, or of diseases or medical conditions that affect the peripheral nerves, the adrenergic and/or cholinergic receptors, the histamine receptors, the expression and/or regulation of growth factors, the skeletal and/or smooth muscle systems, the cardiovascular system, the endocrine and/or hormone systems, the blood circulatory system, the immunological system, the synoptic and neuroeffector junctional sites, the reproductive system, the skeletal system, the autocoid system, the alimentary and/or excretory systems, and/or the central nervous system;Chemicals relating to drug performance and/or drug delivery performance for research use and manufacturing in the biotechnical, biomedical and pharmaceutical industries;Medical devices, namely, medical apparatus in the nature of a unit for aerosol drug delivery to the deep lung of drugs as fine, dry particles, and inhaler devices, sold empty, used to introduce medication into the respiratory system as fine liquid mist for the treatment of respiratory and pulmonary conditions;Technical consulting and research services; namely, providing consultation, research and development services relating to drug performance and/or drug delivery performance to others in the biotechnical, biomedical and pharmaceutical fields;

ENCLESS

Analgesic preparations;

IMMUNIVATION

Pharmaceuticals, namely, pharmaceutical preparations for the treatment and/or prophylaxis of diseases or medical conditions, namely, pharmaceutical preparations for the treatment of cancers; pharmaceuticals, namely, an anti-cancer agent;Research services, namely, providing research and development services for others in the biotechnical, biomedical and pharmaceutical fields;

INVEEOX

Pharmaceutical preparations, namely, an anti-cancer agent;

KALVODI

Analgesic preparations;

NEKTAR

Pharmaceuticals, namely, pharmaceutical preparations having enhanced drug performance and/or drug delivery performance for the treatment and/or prophylaxis of diseases or medical conditions in the nature of diabetes, infections, cancers, and inflammations, or of diseases or medical conditions that affect the peripheral nerves, the adrenergic and/or cholinergic receptors, the histamine receptors, the expression and/or regulations of growth factors, the skeletal and/or smooth muscle systems, the cardiovascular system, the endocrine and/or hormone systems, the blood circulatory system, the immunological system, the synoptic and neuroeffector junctional sites, the reproductive system, the skeletal system, the autocoid system, the alimentary and/or excretory systems, and/or the central nervous system;Color is not claimed as a feature of the mark.;The English translation of the word NEKTAR in the mark is Nectar.;Inhaler devices, sold empty, used to introduce medication into the respiratory system as fine liquid mist for the treatment of respiratory pulmonary conditions; medical devices, namely, medical apparatus in the nature of a unit for aerosol drug delivery to the deep lung of drugs as fine, dry particles;

NEKTAR

Color is not claimed as a feature of the mark.;The English translation of the word NEKTAR in the mark is Nectar.;Research services, namely, providing research and development services for others in the biotechnical, biomedical and pharmaceutical fields;

NEKTAR

Chemicals for use in the manufacture of drugs in the fields of drug performance and drug delivery for the biotechnical, biomedical, and pharmaceutical industries; and chemical preparations for medical, scientific, and manufacturing research use in the fields of drug performance and drug delivery for the biotechnical, and biomedical, and pharmaceutical industries;

NEKTAR

Pharmaceuticals, namely, pharmaceutical preparations having enhanced drug performance and/or drug delivery performance for the treatment and/or prophylaxis of diseases or medical conditions such as diabetes, infections, cancers, and inflammations, or of diseases or medical conditions that affect the peripheral nerves, the adrenergic and/or cholinergic receptors, the histamine receptors, the expression and/or regulation of growth factors, the skeletal and/or smooth muscle systems, the cardiovascular system, the endocrine and/or hormone systems, the blood circulatory system, the immunological system, the synoptic and neuroeffector junctional sites, the reproductive system, the skeletal system, the autocoid system, the alimentary and/or excretory systems, and/or the central nervous system;[ medical devices, namely, medical apparatus in the nature of a unit for aerosol drug delivery to the deep lung of drugs as fine, dry particles ];

NEKTAR

research services, namely, providing research and development services for others in the biotechnical, biomedical and pharmaceutical fields;

NEKTAR

The mark consists of the stylized word NEKTAR.;Pharmaceuticals, namely, pharmaceutical preparations having enhanced drug performance for the treatment of medical conditions in the nature of cancer; pharmaceuticals, namely, pharmaceutical preparations having enhanced drug performance for the treatment of medical conditions affecting peripheral nerves and peripheral nerve pain; pharmaceuticals, namely, pharmaceutical preparations having enhanced drug performance for the treatment of medical conditions affecting the central nervous system and pain in the central nervous system;NECTAR;Color is not claimed as a feature of the mark.;